Skip to main content

Octagon Capital Advisors LP

Position in BIOA — BioAge Labs, Inc.

CIK 1839435 NEW YORK, NY

Position in BIOA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$30,572,520
+$9,430,980 QoQ
Shares Held
1,748,000
+9.4% QoQ
Ownership
3.93%
of shares outstanding
% of Portfolio
3.38%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Octagon Capital Advisors LP holds $30,572,520 across 1 Drug Manufacturers - Specialty & Generic name. BIOA ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BIOA
BioAge Labs, Inc.
This page
1,748,000 $30,572,520

All Filings in BIOA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,572,520 1,748,000
2025-12-31 $21,141,540 1,598,000